Clinical Trial Update: 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating 12-week polysomnography of ropinirole controlled release for restless legs syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Ropinirole controlled release (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Restless Legs Syndrome (RLS), Restless Legs Syndrome | Phase 4 | Status: COMPLETED